查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1602782

抗衰老治療市場：按治療類型、最終用戶、分銷管道分類 - 全球預測 2025-2030

Anti-Ageing Treatment Market by Treatment Type (Abdominoplasty, Acne Treatment, Anti-Pigmentation), End User (40 Years and above, Below 25 Years, Between 25 and 40), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

據預測，2023年抗衰老治療市場價值為479.2億美元，預計到2024年將達到503億美元，複合年成長率為5.06%，到2030年將達到677.3億美元。

調查方法包括旨在減少或預防皺紋、細紋和老年斑等明顯老化跡象的各種產品和技術。這包括乳霜和精華液等局部治療、肉毒桿菌和填充劑等侵入性手術，以及雷射治療和微晶換膚等先進技術。這些治療的需求主要是由於社會標準和預期壽命的延長，人們對更年輕外表的渴望不斷增加。這些療法適用於廣泛的人群，但特別是針對想要保持年輕外觀的中老年人。主要的最終用途領域包括皮膚科診所、健康中心和 DIY 家庭解決方案。

主要市場統計
基準年[2023] 479.2億美元
預測年份 [2024] 503億美元
預測年份 [2030] 677.3億美元
複合年成長率（%） 5.06%

市場成長主要是由於人們對老齡化的認知不斷增強以及先進抗衰老技術的出現。此外，可支配收入的增加和優先考慮年輕外表的文化因素也對需求的成長做出了重大貢獻。然而，市場擴張面臨治療成本高、潛在副作用和嚴格監管限制等挑戰。由於誇大的主張和不切實際的期望導致幻滅，人們對某些治療方法的有效性也普遍持懷疑態度。

儘管存在這些挑戰，但利用天然成分和微創技術開發新型治療方法的機會仍然存在，以滿足對更安全、整體解決方案不斷成長的需求。利用人工智慧和遺傳學根據個人需求客製化抗衰老方案的個人化治療創新顯示出巨大的潛力。抗衰老治療市場充滿活力，受到快速技術進步和消費者偏好轉向不僅保證功效、而且保證永續性和道德採購的產品的推動。為了消除消費者的懷疑，公司和研究人員應專注於嚴格的功效研究和透明的溝通，同時確保創新和道德市場實踐之間的平衡，重點應放在開發具有成本效益的解決方案以吸引更多消費者。

市場動態：揭示快速發展的抗衰老治療市場的關鍵市場洞察

供需的動態交互作用正在改變抗衰老治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 老年人口數量和整容手術數量增加
    • 製造過程中的研究和臨床開發
    • 提高消費者的美容意識
  • 市場限制因素
    • 抗衰老產品高成本且潛在的產品副作用
  • 市場機會
    • 增強人體皮膚彈性和緊緻度的技術進步
    • 高研發投入
  • 市場問題
    • 政府對治療和治療的嚴格規定

波特五力：駕馭抗老治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解抗衰老治療市場的外部影響

外部宏觀環境因素在塑造抗衰老治療市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解抗老治療市場的競爭格局

抗衰老治療市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：抗老治療市場供應商的績效評估

FPNV定位矩陣是評估抗老化治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製抗老治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，抗衰老治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和整容手術增加
      • 生產過程中研究與臨床運動的出現
      • 消費者美容意識不斷增強
    • 抑制因素
      • 抗衰老產品高成本且潛在的產品副作用
    • 機會
      • 增加人體皮膚彈性和緊緻度的技術進步
      • 大量投資於研發
    • 任務
      • 關於程序和治療的嚴格政府規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章抗老治療市場：依治療類型

  • 介紹
  • 腹部手術
  • 痤瘡治療
  • 抗色素沉著
  • 抗張伸治療
  • 皺紋治療
  • 化學換膚
  • 眼瞼手術
  • 頭髮修復
  • 抽脂服務
  • 硬化療法

第7章抗老治療市場：依最終用戶分類

  • 介紹
  • 40歲以上
  • 25歲以下
  • 25-40歲

第8章抗老治療市場：依通路分類

  • 介紹
  • 醫院/診所
  • 豪華沙龍和水療中心

第9章 北美和南美抗衰老治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太抗老治療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲抗老治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie, Inc.
  • Alma Lasers GmBH
  • Bausch Health Companies Inc
  • Beiersdorf AG
  • Carol Cole Company, Inc
  • Clarins Group
  • Estee Lauder Inc.
  • Galderma SA
  • L'Oreal SA
  • Mary Kay Inc.
  • Oriflame Cosmetics Global SA
  • Pierre Fabre Dermo-Cosmetique Usa, Inc.
  • Procter & Gamble Company
  • Proderma Light
  • Sinclair Pharma Group
Product Code: MRR-4358BACA7F08

The Anti-Ageing Treatment Market was valued at USD 47.92 billion in 2023, expected to reach USD 50.30 billion in 2024, and is projected to grow at a CAGR of 5.06%, to USD 67.73 billion by 2030.

The anti-ageing treatment market encompasses a variety of products and methodologies aimed at reducing or preventing the visible signs of ageing, such as wrinkles, fine lines, and age spots. This includes topical treatments like creams and serums, invasive procedures such as Botox and fillers, and advanced technologies like laser therapy and microdermabrasion. The necessity for these treatments primarily stems from the growing desire for youthful appearances, driven by societal standards and increased life expectancy. Application of these treatments spans across diverse demographics, but particularly targets middle-aged to older adults looking to maintain a youthful aesthetic. Key end-use sectors include dermatology clinics, wellness centers, and do-it-yourself home solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 47.92 billion
Estimated Year [2024] USD 50.30 billion
Forecast Year [2030] USD 67.73 billion
CAGR (%) 5.06%

Market growth is notably influenced by increasing awareness about ageing and the availability of advanced anti-ageing technologies. Additionally, rising disposable incomes and cultural factors that prioritize youthful looks significantly contribute to the growing demand. However, market expansion faces challenges from high treatment costs, potential side effects, and stringent regulatory constraints. There is also a growing skepticism about the efficacy of certain treatments due to exaggerated claims and disillusionment following unrealistic expectations.

Despite these challenges, opportunities abound in the development of novel treatments that utilize natural ingredients and minimally invasive technologies, catering to a growing demand for safer and more holistic solutions. Innovations in personalized treatments, leveraging artificial intelligence and genetics to tailor anti-ageing regimens to individual needs, show promising potential. The market for anti-ageing treatment is dynamic, driven by rapid technological advancements and shifts in consumer preferences towards products that promise not only efficacy but also sustainability and ethical sourcing. Businesses and researchers should focus on rigorous efficacy studies and transparent communication to address consumer skepticism, and on developing cost-effective solutions to capture a broader audience, ensuring a balance between innovation and ethical market practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Ageing Treatment Market

The Anti-Ageing Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population coupled with rising number of cosmetic surgeries
    • Emergence of research studies and clinical movements in the production process
    • Growing awareness of beauty in consumers
  • Market Restraints
    • High cost of anti-aging products and possibility of side effects of products
  • Market Opportunities
    • Technological advancement in enhancement of human skin elasticity and tightness
    • High investment for research and development
  • Market Challenges
    • Stringent government regulations for procedure and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Ageing Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Ageing Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Ageing Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Ageing Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Ageing Treatment Market

A detailed market share analysis in the Anti-Ageing Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Ageing Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Ageing Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anti-Ageing Treatment Market

A strategic analysis of the Anti-Ageing Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anti-Ageing Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers GmBH, Bausch Health Companies Inc, Beiersdorf AG, Carol Cole Company, Inc, Clarins Group, Estee Lauder Inc., Galderma SA, L'Oreal SA, Mary Kay Inc., Oriflame Cosmetics Global SA, Pierre Fabre Dermo-Cosmetique Usa, Inc., Procter & Gamble Company, Proderma Light, and Sinclair Pharma Group.

Market Segmentation & Coverage

This research report categorizes the Anti-Ageing Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Abdominoplasty, Acne Treatment, Anti-Pigmentation, Anti-Stretch Treatment, Anti-Wrinkle Treatment, Chemical Peel, Eyelid Surgery, Hair Restoration, Liposuction Service, and Sclerotherapy.
  • Based on End User, market is studied across 40 Years and above, Below 25 Years, and Between 25 and 40.
  • Based on Distribution Channel, market is studied across Hospitals & Clinics and Luxury Salons & Spas.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population coupled with rising number of cosmetic surgeries
      • 5.1.1.2. Emergence of research studies and clinical movements in the production process
      • 5.1.1.3. Growing awareness of beauty in consumers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of anti-aging products and possibility of side effects of products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in enhancement of human skin elasticity and tightness
      • 5.1.3.2. High investment for research and development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for procedure and treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Ageing Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Abdominoplasty
  • 6.3. Acne Treatment
  • 6.4. Anti-Pigmentation
  • 6.5. Anti-Stretch Treatment
  • 6.6. Anti-Wrinkle Treatment
  • 6.7. Chemical Peel
  • 6.8. Eyelid Surgery
  • 6.9. Hair Restoration
  • 6.10. Liposuction Service
  • 6.11. Sclerotherapy

7. Anti-Ageing Treatment Market, by End User

  • 7.1. Introduction
  • 7.2. 40 Years and above
  • 7.3. Below 25 Years
  • 7.4. Between 25 and 40

8. Anti-Ageing Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Luxury Salons & Spas

9. Americas Anti-Ageing Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Anti-Ageing Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Anti-Ageing Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Alma Lasers GmBH
  • 3. Bausch Health Companies Inc
  • 4. Beiersdorf AG
  • 5. Carol Cole Company, Inc
  • 6. Clarins Group
  • 7. Estee Lauder Inc.
  • 8. Galderma SA
  • 9. L'Oreal SA
  • 10. Mary Kay Inc.
  • 11. Oriflame Cosmetics Global SA
  • 12. Pierre Fabre Dermo-Cosmetique Usa, Inc.
  • 13. Procter & Gamble Company
  • 14. Proderma Light
  • 15. Sinclair Pharma Group

LIST OF FIGURES

  • FIGURE 1. ANTI-AGEING TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-AGEING TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-AGEING TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-AGEING TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ABDOMINOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ACNE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-PIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-STRETCH TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY ANTI-WRINKLE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY CHEMICAL PEEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HAIR RESTORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LIPOSUCTION SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY 40 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BELOW 25 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY BETWEEN 25 AND 40, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-AGEING TREATMENT MARKET SIZE, BY LUXURY SALONS & SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ANTI-AGEING TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ANTI-AGEING TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. ANTI-AGEING TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ANTI-AGEING TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023